Here's a counterintuitive truth: the companies best positioned to be disrupted are also the ones best positioned to own the disruption. The question isn't whether your industry will change. It's whether you'll be the one building what comes next.

For the past decade, corporate venture capital was the default answer to the innovation problem. CVCs grew to participate in roughly 20% of all venture deals, and in AI, corporate venture arms accounted for nearly 75% of recent VC activity. The bet was simple: if you can't out-build the startups threatening your business, at least own a piece of them.

But that model is under pressure. CVC activity is declining. One-third of active CVC units were shut down or mothballed over the past three years. Innovation budgets are contracting. And the returns, strategic and financial, haven't justified the investment for most of the corporations that tried it.

The problem isn't that corporations shouldn't be building the next wave of their industries. It's that passive investment was never the right tool to do it.

What CVCs are getting wrong

The logic of investing in potential disruptors is sound. The execution is where most corporate venture programs break down, and the pattern is consistent.

CVC units that start with strategic intent tend to drift toward financial returns over time. They get structurally isolated from the business units they're supposed to inform. Investment decisions get made without a clear line back to what the corporation actually needs to learn or build. And when market conditions tighten, they're the first budget cut, because no one can articulate exactly what they delivered.

Intel Capital is the cautionary tale. It generated over 700 exits across 1,800 investments and helped build the ecosystem around Intel's next-generation chips. But around 2007, the team shifted from small, strategic bets to larger, less actionable investments and became increasingly siloed from Intel's core. Eventually it wasn't enough to steer Intel through market challenges: Intel posted $19 billion in losses in 2024.

Why an independent startup is the right vehicle

So if passive investment isn't enough, the obvious next move is to build in-house. Most corporations have tried this too, through innovation labs, internal incubators, and skunkworks teams. The results are rarely better. Here's why: you cannot build a disruptive venture inside your own walls.

The internal approval processes, risk tolerance, incentive structures, and brand considerations that make a large corporation stable are exactly the things that make it incapable of moving at startup speed. The answer isn't to lower internal standards. It's to build outside them. An independent startup can move faster, recruit differently, price differently, and serve customers the parent company can't or won't. It plays by startup rules. And when it's built with a corporate partner's data, distribution, customer relationships, and domain expertise embedded from day one, it has a structural advantage no purely independent competitor can replicate. That's what we mean by an advantaged startup.

Disrupt yourself before someone else does

When Novartis wanted to develop a new class of cardiovascular therapies, they didn't run it through internal R&D. They spun out Anthos Therapeutics as an independent joint venture, deliberately giving it the freedom to recruit specialized talent, raise outside capital, and move at a pace Novartis's internal processes couldn't match. It worked: Novartis acquired Anthos back for $3.1 billion once the venture had proven the science and built the asset. The independence wasn't a concession. It was the strategy.

The same logic applies in financial services, healthcare, energy, and logistics. The question isn't whether your organization has a stake in the startups solving your industry's hardest problems. It's whether you're the one building them, with your market access, your customer relationships, and your domain expertise embedded from day one.

Pet health leader, Elanco, didn't just invest in the carbon credit space. Working with Alloy Partners, they co-created Athian, the first carbon marketplace for livestock. That venture accelerated the path to market for a premium product that Elanco cites as a $200 million annual revenue opportunity, and 2/3 of the U.S. dairy industry was represented in Athian's seed round. The venture wasn't adjacent to Elanco's strategy. It was the strategy.

That's what venture building done right looks like, not a hedge against disruption, but a way to lead the category you're already in. The companies that act now will shape what their industries look like in 2030. The ones that wait will fund whoever does.

If you're a corporate innovation or strategy leader thinking about how to get ahead of the next wave, let's talk about what co-creating an advantaged startup could look like for your organization. Reach out to the Alloy Partners team →